Results 251 to 260 of about 1,304,702 (391)
Chronic Diseases and Translational Medicine, EarlyView.Donanemab, approved by the U.S. FDA in July 2024, targets amyloid plaques in the brain to treat Alzheimer's disease in patients with mild cognitive impairment or mild dementia. ABSTRACT Substantial research has been conducted to identify an efficient treatment for Alzheimer's disease (AD).
Nandhini Jayaprakash +1 more
wiley +1 more source
Green human resource practices for individual environmental performance: A meta‐review
Canadian Journal of Administrative Sciences / Revue Canadienne des Sciences de l'Administration, EarlyView.Abstract The field of green human resource management is a discreet but paradoxically very dynamic research topic. While many literature reviews have been published in recent years, none have explicitly addressed the links with environmental performance. This paper aims to fill this gap.
Pascal Paillé
wiley +1 more source
Health Professionals' Attitudes Towards Traditional Healing for Mental Illness: A Systematic Review. [PDF]
Int J Ment Health NursWollie AM, Usher K, Rice K, Islam MS.
europepmc +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.Older adults (65 years and over) frequently manage complex medication regimens and are vulnerable to adverse drug reactions and treatment inefficacies, some of which could be preventable with pharmacogenetics (PGx)‐guided prescribing. This study examined the prevalence of actionable PGx genotypes (i.e., those linked to a guideline that recommends a ...
Chad A. Bousman +14 more
wiley +1 more source
Sexual trauma and interest in mobile health among women with mental illness in Ghana. [PDF]
Internet IntervBen-Zeev D +12 more
europepmc +1 more source